NCT07102186
Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 2 words Show 5 more changesShow less
- Trial completed
- Final enrollment: 93 participants (planned 120)
- Secondary endpoints: details revised at 3 of 3 entries
- Study description revised
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Local tolerance to the drugs scale
Timeframe: 8 weeks
Secondary (3)
investigator's global assessment (IGA)
acne severity index
skin turgor assessment
Arms and interventions
adapalene gel 0.1% once daily at bedtimeActive comparator
adapalene gel 0.1% once daily at bedtime and hyaluronic acidExperimental
Drugs: use of adapalene gel 0.1% and hyaluronic acid at bedtime, use of adapalene gel 0.1% once daily at bedtime
Sites
1 site in 1 country
- Badr university in CairoCairo, Cairo Governorate, Egypt